Erytech Pharma Granted Australia Patent Titled ‘Arginine Deiminase Encapsulated Inside Erythrocytes And Their Use In Treating Cancer’

Auto giant General Motors-backed Beijing Momenta Technology Co., a Chinese self-driving firm, has quietly filed for a potential IPO in the U.S., report says. Momenta reportedly aims to raise $200-$300 million through share sales, with discussions ongoing. The move underscores Momenta's rapid growth and signifies a significant step in its global expansion strategy.